Research shows weight loss from GLP-1 therapy has a direct positive effect on testosterone in men. Here is what the data shows and which markers to track.
Quick Summary Research consistently shows that obesity suppresses testosterone through multiple mechanisms. GLP-1 therapy, which drives significant weight loss, has been shown in published studies to raise testosterone in men with obesity-associated hypogonadism. Educational purposes only -- not medical advice.
Aromatase Activity -- Adipose tissue contains aromatase which converts testosterone to estradiol. Higher body fat means more aromatase activity and lower testosterone.
Leptin and HPT Axis Suppression -- Research shows chronically elevated leptin suppresses GnRH release, leading to reduced LH and reduced testicular testosterone production.
SHBG Reduction -- Research shows obesity reduces SHBG, which also means faster testosterone clearance and lower bioavailable testosterone.
Insulin Resistance -- Research shows insulin resistance directly impairs Leydig cell function and testosterone production.
Track your testosterone panel at [myprotocolstack.com/labs](https://myprotocolstack.com/labs).
A 2023 study published in Diabetes, Obesity and Metabolism showed semaglutide therapy was associated with significant total testosterone increases in men with obesity and hypogonadism over 6 months.
The magnitude of effect depends on starting weight, degree of weight loss, and baseline testosterone levels.
Total and Free Testosterone + SHBG -- Draw at baseline, 12 weeks, and 24 weeks for trend data.
LH and FSH -- Rising LH alongside rising testosterone confirms the HPT axis is recovering.
Estradiol -- Should trend downward in men as body fat decreases and aromatase activity decreases.
HbA1c and Fasting Insulin -- Metabolic improvement often precedes or accompanies hormonal improvement.
Use [StackAI](https://myprotocolstack.com/stackai) to analyze your testosterone panel alongside your GLP-1 protocol markers.
Can GLP-1 replace testosterone therapy in men with low T?
Research shows GLP-1-induced weight loss can normalize testosterone in men with obesity-related secondary hypogonadism. It does not treat primary hypogonadism.
How long does it take to see testosterone improvements on GLP-1?
Published studies show meaningful changes at 6-12 months corresponding to significant weight loss milestones.
Will my testosterone stay elevated if I stop GLP-1?
Research on weight regain after GLP-1 discontinuation shows significant weight return in most patients. Whether testosterone changes are sustained depends on maintaining the underlying weight loss.
Should I get my testosterone checked before starting GLP-1?
Yes. A baseline testosterone panel provides the reference point needed to document changes over time.
What is the connection between semaglutide and testosterone?
The effect is mediated through weight loss and metabolic improvement rather than a direct hormonal effect of semaglutide itself.
*This article is for educational purposes only. Consult a licensed healthcare provider for hormone evaluation and treatment decisions.*
*Written by the MyProtocolStack team. Last updated: March 2026.*
Enter your blood work in MyProtocolStack, run StackAI analysis, and get personalized insights based on your actual numbers -- not generic charts.
Start Free →